サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1519472

プロテインエンジニアリング市場レポート：製品・サービス、タンパク質タイプ、技術、エンドユーザー、地域別、2024年～2032年

Protein Engineering Market Report by Product & Services, Protein Type, Technology, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 140 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
プロテインエンジニアリング市場レポート：製品・サービス、タンパク質タイプ、技術、エンドユーザー、地域別、2024年～2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のプロテインエンジニアリング市場規模は2023年に33億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに78億米ドルに達し、2024年から2032年の間に9.9％の成長率（CAGR）を示すと予測しています。

タンパク質工学とは、タンパク質の塩基配列を開発または変更して、望ましい結果を得るプロセスを指します。新しいタンパク質の合成や既存の構造や配列の変更を含み、新規の機能強化のためにアミノ酸配列を変更する組換えデオキシリボ核酸（DNA）技術を用います。この技術は、工業的に使用する酵素やタンパク質の大量生産に広く利用されています。近年、研究者は、医療、研究、産業、健康、バイオテクノロジーの用途に合わせた様々なタンパク質の設計に成功し、世界中でその需要が高まっています。

プロテインエンジニアリング市場動向：

合成生物学への投資の高まりと、タンパク質をベースとした医薬品開発への注目の高まりが、市場開拓の主な促進要因となっています。さらに、タンパク質医薬品の臨床結果が良好であることから、非タンパク質医薬品からタンパク質治療薬へのシフトが著しいです。これは、タンパク質欠乏性疾患の蔓延と相まって、タンパク質工学の需要を増大させています。さらに、タンパク質工学分野における研究開発（R&D）活動への資金提供の増加など、各国政府によるいくつかの有利な取り組みが、市場の成長を後押ししています。これに加えて、組み換えモノクローナル抗体（mAbs）の登場や、がんや自己免疫疾患など様々な疾患の治療におけるモノクローナル抗体の使用量の増加が、製品の採用率を加速させています。さらに、農薬業界では、作物の収穫量を増やしたり、バイオ燃料の生産を促進したりするために、機能を強化した酵素を生成するタンパク質工学の応用研究が進行しており、市場成長の触媒となっています。個別化医薬品に対する需要の高まり、バイオシミラーや生物製剤に対するニーズの高まり、ヘルスケアインフラの改善、技術の進歩、製品の革新など、その他の要因も市場に明るい見通しをもたらしています。

本レポートで扱う主な質問

  • 2023年における世界のプロテインエンジニアリング市場の市場規模は？
  • 2024-2032年における世界のプロテインエンジニアリング市場の予想成長率は？
  • 世界のプロテインエンジニアリング市場を牽引する主な要因は？
  • 世界のプロテインエンジニアリング市場に対するCOVID-19の影響は？
  • 世界のプロテインエンジニアリング市場の製品・サービス別内訳は？
  • 世界のプロテインエンジニアリング市場のタンパク質のタイプ別の内訳は？
  • 世界のプロテインエンジニアリング市場のエンドユーザー別の内訳は？
  • 世界のプロテインエンジニアリング市場の主要地域は？
  • 世界のプロテインエンジニアリング市場の主要プレーヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のプロテインエンジニアリング市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品・サービス別

  • 機器
    • 市場動向
    • 市場予測
  • 試薬
    • 市場動向
    • 市場予測
  • サービスとソフトウェア
    • 市場動向
    • 市場予測

第7章 市場内訳：タンパク質タイプ別

  • インスリン
    • 市場動向
    • 市場予測
  • モノクローナル抗体
    • 市場動向
    • 市場予測
  • 凝固因子
    • 市場動向
    • 市場予測
  • ワクチン
    • 市場動向
    • 市場予測
  • 成長因子
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：技術別

  • 非合理的なタンパク質設計
    • 市場動向
    • 市場予測
  • 合理的なタンパク質設計
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 製薬・バイオテクノロジー企業
    • 市場動向
    • 市場予測
  • 学術研究機関
    • 市場動向
    • 市場予測
  • 契約研究機関
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abzena Ltd.
    • Agilent Technologies Inc.
    • Amgen Inc.
    • Bio-Rad Laboratories Inc.
    • Bruker Corporation
    • Codexis Inc.
    • Danaher Corporation
    • Eli Lilly and Company
    • General Electric Company
    • Merck KGaA
    • Novo Nordisk A/S
    • PerkinElmer Inc.
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
図表

List of Figures

  • Figure 1: Global: Protein Engineering Market: Major Drivers and Challenges
  • Figure 2: Global: Protein Engineering Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Protein Engineering Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Protein Engineering Market: Breakup by Product & Services (in %), 2023
  • Figure 5: Global: Protein Engineering Market: Breakup by Protein Type (in %), 2023
  • Figure 6: Global: Protein Engineering Market: Breakup by Technology (in %), 2023
  • Figure 7: Global: Protein Engineering Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Protein Engineering Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Protein Engineering (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Protein Engineering (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Protein Engineering (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Protein Engineering (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Protein Engineering (Services and Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Protein Engineering (Services and Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Protein Engineering (Insulin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Protein Engineering (Insulin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Protein Engineering (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Protein Engineering (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Protein Engineering (Coagulation Factors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Protein Engineering (Coagulation Factors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Protein Engineering (Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Protein Engineering (Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Protein Engineering (Growth Factors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Protein Engineering (Growth Factors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Protein Engineering (Other Protein Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Protein Engineering (Other Protein Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Protein Engineering (Irrational Protein Design) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Protein Engineering (Irrational Protein Design) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Protein Engineering (Rational Protein Design) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Protein Engineering (Rational Protein Design) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Protein Engineering (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Protein Engineering (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Protein Engineering (Academic Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Protein Engineering (Academic Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Protein Engineering (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Protein Engineering (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Protein Engineering Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Protein Engineering Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Protein Engineering Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Protein Engineering Industry: SWOT Analysis
  • Figure 87: Global: Protein Engineering Industry: Value Chain Analysis
  • Figure 88: Global: Protein Engineering Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Protein Engineering Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Protein Engineering Market Forecast: Breakup by Product & Services (in Million US$), 2024-2032
  • Table 3: Global: Protein Engineering Market Forecast: Breakup by Protein Type (in Million US$), 2024-2032
  • Table 4: Global: Protein Engineering Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Protein Engineering Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Protein Engineering Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Protein Engineering Market: Competitive Structure
  • Table 8: Global: Protein Engineering Market: Key Players
目次
Product Code: SR112024A5005

The global protein engineering market size reached US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.8 Billion by 2032, exhibiting a growth rate (CAGR) of 9.9% during 2024-2032.

Protein engineering refers to the process of developing or changing a protein sequence to achieve the desired result. It involves the synthesis of new proteins or amendments in the existing structure or sequence and employs recombinant deoxyribonucleic acid (DNA) technology to alter amino acid sequences for novel and enhanced functions. It is widely utilized for the production of enzymes or proteins in large quantities for use in industrial settings. In recent years, researchers have successfully engineered a wide range of proteins tailored to medicine, research, industry, health, and biotechnology applications, which is escalating their demand across the globe.

Protein Engineering Market Trends:

The rising investments in synthetic biology and the improving focus toward protein-based drug development represent the primary factors driving the market growth. Additionally, there has been a significant shift toward protein therapeutics from non-protein drugs due to their associated positive clinical outcomes. This, in confluence with the widespread prevalence of protein-deficient diseases, is increasing the demand for protein engineering. Furthermore, several favorable initiatives undertaken by the government of various countries, such as increased funding for research and development (R&D) activities in the field of protein engineering, are propelling the market growth. Besides this, the advent of recombinant monoclonal antibodies (mAbs) and the increasing usage of monoclonal antibodies to treat various diseases, such as cancer and autoimmune diseases, are accelerating product adoption rates. Moreover, the ongoing research for applications of protein engineering in the agrochemical industry to generate enzymes with enhanced function to increase the crop yield or facilitate biofuel production is catalyzing the market growth. Other factors, including the escalating demand for personalized medicines, growing need for biosimilars and biologics, improving healthcare infrastructure, technological advancements, and product innovations, are also creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global protein engineering market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product & services, protein type, technology and end user.

Breakup by Product & Services:

Instruments

Reagents

Services and Software

Breakup by Protein Type:

Insulin

Monoclonal Antibodies

Coagulation Factors

Vaccines

Growth Factors

Others

Breakup by Technology:

Irrational Protein Design

Rational Protein Design

Breakup by End User:

Pharmaceutical and Biotechnology Companies

Academic Research Institutes

Contract Research Organizations

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abzena Ltd., Agilent Technologies Inc., Amgen Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Codexis Inc., Danaher Corporation, Eli Lilly and Company, General Electric Company, Merck KGaA, Novo Nordisk A/S, PerkinElmer Inc., Thermo Fisher Scientific Inc. and Waters Corporation.

Key Questions Answered in This Report

  • 1. What was the size of the global protein engineering market in 2023?
  • 2. What is the expected growth rate of the global protein engineering market during 2024-2032?
  • 3. What are the key factors driving the global protein engineering market?
  • 4. What has been the impact of COVID-19 on the global protein engineering market?
  • 5. What is the breakup of the global protein engineering market based on the product and services?
  • 6. What is the breakup of the global protein engineering market based on the protein type?
  • 7. What is the breakup of the global protein engineering market based on the technology?
  • 8. What is the breakup of the global protein engineering market based on the end user?
  • 9. What are the key regions in the global protein engineering market?
  • 10. Who are the key players/companies in the global protein engineering market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Protein Engineering Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product & Services

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services and Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Protein Type

  • 7.1 Insulin
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Monoclonal Antibodies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Coagulation Factors
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Vaccines
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Growth Factors
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Irrational Protein Design
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Rational Protein Design
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Contract Research Organizations
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abzena Ltd.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Agilent Technologies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Amgen Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Bio-Rad Laboratories Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Bruker Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Codexis Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Danaher Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Eli Lilly and Company
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 General Electric Company
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Merck KGaA
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Novo Nordisk A/S
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 PerkinElmer Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Thermo Fisher Scientific Inc.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Waters Corporation
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis